All posts in
Norway Brings Another Cancer Vaccine to the Clinic
UPDATE: Norwegian Stock Exchange hits Record Biotech IPO
Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies
Can Oncolytic Viruses be the key to Treat Resistant Tumors?
Can this new Antibody-Drug Conjugate Collaboration make it to the Top?
On the way to a ‘Functional’ HIV Cure? Norway Vaccine clears viral load in 88% of Patients
Biotech of the Week: Avexxin, reducing inflammatory diseases from far up in Norway
Biotech of the week: Nordic Nanovector & its ARC technology
World First: Scotland and Norway have Founded a Unique Oceanic Algae Plant
Norway’s €1.3Bn Cancer Innovation Park opens!
Polaris, a new Nordic leader in Immuno-Oncology
Nordic Nanovector, the Norwegian rising star
Labiotech UG, All Rights Reserved -
Send this to friend